1.
Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery – Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg 2002; 94:1052–64.Google Scholar
2.
Ouchterlony J, Arvidsson S, Sjostedt L, Svardsudd K. Perioperative and immediate postoperative adverse events in patients undergoing elective general and orthopaedic surgery. Acta Anaesthesiol Scand 1995; 39:643–52.CrossrefGoogle Scholar
3.
Schwilk B, Muche R, Treiber H, Brinkmann A, Georgieff M, Bothner U. A cross-validated multifactorial index of perioperative risks in adults undergoing anaesthesia for non-cardiac surgery. J Clin Monit 1998; 14:283–94.CrossrefGoogle Scholar
4.
Mangano DT, Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med 1995; 338:1750–6.Google Scholar
5.
Panteghini M. Role and importance of biochemical markers in clinical cardiology. Eur Heart J 2004; 25:1187–96.CrossrefGoogle Scholar
6.
Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, et al. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001; 47:464–70.Google Scholar
7.
Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004; 97:297–301.Google Scholar
8.
Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D, et al. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise induced skeletal muscle ischemia. Clin Chem 2004; 50:1656–60.CrossrefGoogle Scholar
9.
Wu AH. The ischemia-modified albumin biomarker for myocardial ischemia. MLO Med Lab Obs 2003; 35:36–8.Google Scholar
10.
Anwaruddin S, Januzzi JL Jr, Baggish AL, Lewandrowski EL, Lewandrowski KB. Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol 2005; 123:140–5.Google Scholar
11.
Montagnana M, Lippi G, Fava C, Minuz P, Lechi Santonastaso C, Arosio E, et al. Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease. Clin Chem Lab Med 2006; 44:207–12.CrossrefGoogle Scholar
12.
Ng LL, Loke IW, Davies JE, Geeranavar S, Khunti K, Stone MA, et al. Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides. J Am Coll Cardiol 2005; 45:1043–50.CrossrefGoogle Scholar
13.
Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: molecular aspects. Eur J Heart Fail 2004; 6:261–8.CrossrefGoogle Scholar
14.
Collinson PO, Barnes SC, Gaze DC, Galasko G, Lahiri A, Senior R. Analytical performance of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 2004; 6:365–8.Google Scholar
15.
Jarai R, Wojta J, Huber K. Circulating B-type natriuretic peptides in patients with acute coronary syndromes. Pathophysiological, prognostical and therapeutical considerations. Thromb Haemost 2005; 94:926–32.Google Scholar
16.
Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation 1981; 63:1391–8.CrossrefGoogle Scholar
17.
Gidenne S, Ceppa F, Fontan E, Perrier F, Burnat P. Analytical performance of the Albumin Cobalt Binding (ACB) test on the Cobas MIRA Plus analyzer. Clin Chem Lab Med 2004; 42:455–61.CrossrefGoogle Scholar
18.
Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NR, et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 1996; 27:910–48.Google Scholar
19.
Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 1990; 323:1781–8.Google Scholar
20.
Raby KE, Goldman L, Creager MA, Cook EF, Weisberg MC, Whittemore AD, et al. Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med 1989; 321:1296–300.Google Scholar
21.
Raby KE, Barry J, Creager MA, Cook EF, Weisberg MC, Goldman L. Detection and significance of intraoperative and postoperative myocardial ischemia in peripheral vascular surgery. J Am Med Assoc 1992; 268:222–7.CrossrefGoogle Scholar
22.
Hobisch-Hagen P, Schobersberger W, Falkensammer J, Luz G, Innerhofer P, Frischhut B, et al. No release of cTnI during major orthopedic surgery after acute normovolemic hemodilution. Acta Anaesthesiol Scand 1998; 42:799–804.CrossrefGoogle Scholar
23.
Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. American College of Physicians. Ann Intern Med 1997;127:309–12.PubMedGoogle Scholar
24.
Vuolteenaho O, Ala-Kopsala M, Ruskoaho H. BNP as a biomarker in heart disease. Adv Clin Chem 2005; 40:1–36.CrossrefGoogle Scholar
25.
Kikuta K, Yasue H, Yoshimura M, Morita E, Sumida H, Kato H, et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J 1996; 132:101–7.CrossrefGoogle Scholar
26.
Jernberg T, Stridsberg M, Venge P, Lindahl B. N-Terminal pro-brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST segment elevation. J Am Coll Cardiol 2002; 40:437–45.CrossrefGoogle Scholar
27.
Campbell DJ, Munir V, Hennessy OF, Dent AW. Plasma aminoterminal pro-brain natriuretic peptide levels in subjects presenting to the emergency department with suspected acute coronary syndrome: possible role in selecting patients for follow up? Intern Med J 2001; 31:211–9.CrossrefGoogle Scholar
28.
Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, et al. N-Terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002; 106:2913–8.CrossrefGoogle Scholar
29.
Hong SN, Yoon NS, Ahn Y, Lim SY, Kim YS, Yun KH, et al. N-terminal pro-B-type natriuretic peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes. Circ J 2005; 69:1472–6.CrossrefGoogle Scholar
30.
Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 2004; 50:33–50.CrossrefGoogle Scholar
31.
Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljungdahl L, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992; 327:146–50.Google Scholar
32.
Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation 1996; 94:1291–7.CrossrefGoogle Scholar
33.
Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. Br Med J 1996; 313:262–4.Google Scholar
34.
Provenchere S, Berroeta C, Reynaud C, Baron G, Poirier I, Desmonts JM, et al. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 2006; 34:995–1000.Google Scholar
35.
Adams JE, Sicard GA, Allen BT, Bridwell KH, Lenke LG, Davila-Roman VG, et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 1994; 330:670–4.Google Scholar
36.
Lee TH, Thomas EJ, Ludwig LE, Sacks DB, Johnson PA, Donaldson MC, et al. Troponin T as a marker for myocardial ischemia in patients undergoing major noncardiac surgery. Am J Cardiol 1996; 77:1031–6.CrossrefGoogle Scholar
37.
Metzler H, Gries M, Rehak P, Lang T, Fruhwald S, Toller W. Perioperative myocardial cell damage: the role of troponins. Br J Anaesth 1997; 78:386–90.CrossrefGoogle Scholar
38.
Mahla E, Tiesenhausen K, Rehak P, Fruhwald S, Purstner P, Metzler H. Perioperative myocardial cell injury: the relationship between troponin T and cortisol. J Clin Anesth 2000; 12:208–12.CrossrefGoogle Scholar
39.
Jules-Elysee K, Urban MK, Urquhart B, Milman S. Troponin I as a diagnostic marker of a perioperative myocardial infarction in the orthopedic population. J Clin Anesth 2001; 13:556–60.CrossrefGoogle Scholar
40.
Neill F, Sear JW, French G, Lam H, Kemp M, Hooper RJ, et al. Increases in serum concentrations of cardiac proteins and the prediction of early postoperative cardiovascular complications in noncardiac surgery patients. Anaesthesia 2000; 55:641–7.CrossrefGoogle Scholar
41.
Storrow AB, Gibler WB. Chest pain centers: diagnosis of acute coronary syndromes. Ann Emerg Med 2000; 35:449–61.CrossrefGoogle Scholar
42.
Lippi G, Brocco G, Salvagno GL, Montagnana M, Dima F, Guidi GC. High-workload endurance training may increase serum ischemia-modified albumin concentrations. Clin Chem Lab Med 2005; 43:741–4.CrossrefGoogle Scholar
43.
Wang YF, Gwathmey JK, Zhang G, Soriano SG, He S, Wang Y. Cerebrospinal fluid may mediate CNS ischemic injury. Cerebrospinal Fluid Res 2005; 2:7.Google Scholar
44.
Collinson PO. Biomarkers in angina. Scand J Clin Lab Invest 2005; 240:86–92.Google Scholar
45.
Milionis HJ, Liberopoulos E, Goudevenos J, Bairaktari ET, Seferiadis K, Elisaf MS. Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals. Int J Cardiol 2005; 99:269–75.CrossrefGoogle Scholar
46.
Dziedzic T, Slowik A, Szczudlik A. Serum albumin level as a predictor of ischemic stroke outcome. Stroke 2004; 35:156–8.CrossrefGoogle Scholar
47.
Roy D, Quiles J, Sinha M, Aldama G, Gaze D, Kaski JC. Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am J Cardiol 2004; 93:366–8.CrossrefGoogle Scholar
48.
McCord J. Oxygen-derived free radicals in post ischemic tissue injury. N Engl J Med 1985; 312:159–63.Google Scholar
49.
Cobbe SM, Poole-Wilson PA. The time of onset and severity of acidosis in the myocardial ischemia. J Mol Cell Biol 1980; 12:745–60.Google Scholar
50.
Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A. High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem 2004; 50:2190–3.CrossrefGoogle Scholar
51.
Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of “ischemia modified albumin”, a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004; 21:29–34.CrossrefGoogle Scholar
52.
Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003; 49:581–5.CrossrefGoogle Scholar
53.
van der Zee PM, Verberne HJ, van Straalen JP, Sanders GT, Van Eck-Smit BL, de Winter RJ, et al. Ischemia-modified albumin measurements in symptom-limited exercise myocardial perfusion scintigraphy reflect serum albumin concentrations but not myocardial ischemia. Clin Chem 2005; 51:1744–6.CrossrefGoogle Scholar
54.
Lippi G, Montagnana M, Guidi GC. Predicting cardiac outcomes. Can Med Assoc J 2005; 173:1206–7.Google Scholar
Comments (0)